CD4 and type 1 diabetes mellitus: These findings underscore the importance of early immune dysregulation and cellular heterogeneity within CD4+ T cell compartment in type 1 diabetes pathogenesis, offering novel insights into aberrant temporal and cell-type–specific immune regulation driving disease progression.